Alliancebernstein L.P. Atreca, Inc. Transaction History

Alliancebernstein L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.56 - $3.25 $19,656 - $40,950	-12,600 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.61 - $5.2 $16,744 - $54,080	-10,400 Reduced 45.22%	12,600 $40,000
Q4 2021 Feb 14, 2022	SELL	$2.87 - $6.29 $11,767 - $25,789	-4,100 Reduced 15.13%	23,000 $70,000
Q2 2021 Jul 30, 2021	BUY	$7.82 - $13.8 $48,484 - $85,560	6,200 Added 29.67%	27,100 $231,000
Q1 2021 May 06, 2021	SELL	$13.0 - $19.34 $31,200 - $46,416	-2,400 Reduced 10.3%	20,900 $320,000
Q4 2020 Feb 08, 2021	BUY	$13.03 - $17.09 $19,545 - $25,635	1,500 Added 6.88%	23,300 $376,000
Q3 2020 Nov 12, 2020	SELL	$12.67 - $23.19 $7,602 - $13,914	-600 Reduced 2.68%	21,800 $305,000
Q2 2020 Aug 13, 2020	BUY	$12.52 - $23.45 $103,916 - $194,635	8,300 Added 58.87%	22,400 $477,000
Q1 2020 May 14, 2020	BUY	$11.4 - $27.28 $160,740 - $384,648	14,100 New	14,100 $233,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.